Where does David Sidransky work?

David Sidransky is Co-Founder and Managing Partner at Israel Biotech Fund.

What boards does David Sidransky sit on?

David Sidransky holds tracked board seats at Advaxis, Advaxis, Champions Oncology, Galmed Pharmaceuticals, Orgenesis, Tamir Biotechnology.

Where did David Sidransky go to school?

David Sidransky studied at Baylor College of Medicine (md, internal medicine); Brandeis University (bs, chemistry).

David Sidransky

Investor

Co-Founder and Managing Partner at Israel Biotech Fund

Pikesville, Maryland, United States

Find your path to David

235 people in our graph share verified history with David — schools, employers, funds. One of them is your warm intro.

Nicole GaudelliunlockedDavid: together at Johns Hopkins University (2006–2013)

×9David: together at Brandeis University

David: together at Teva Pharmaceuticals

David: together at Baylor College of Medicine

Contact· self-published, not guessed

d•••@ibf.fundreveal

Experience

Johns Hopkins UniversityProfessorcurrent1988 — present
Champions Oncology, Inc.Member Board of Directorscurrent2016 — present
Champions Oncology, Inc.Chairman of the Board2008 — 2016
Galmed Pharmaceuticals Ltd.Board Membercurrent2014 — present
Ayala PharmaceuticalsChairman of the Board2019 — 2025
Advaxis, Inc.Chairman of the Board2013 — 2024
Orgenesis Inc.Member Board of Directors2013 — 2024
Tamir BiotechnologyChairman of the Board2007 — 2020
Rosetta GenomicsMember of the Board of Directors2009 — 2017
Celsus Therapeutics PLCMember of the Board of Directors2012 — 2015
KV PharmaceuticalDirector2010 — 2012St louis MO
Maimonides Academy of BaltimoreChairman of the Board2008 — 2010
Teva Pharmaceuticalsconsultant2007 — 2010
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and CompanyMember of the Board of Directors2005 — 2009
ImClone Systems, a wholly-owned subsidiary of Eli Lilly and CompanyVice chairman of the board2005 — 2008
American Association for Cancer Researchdirector2006 — 2008

Skills & more

Oncology82Urology26Genetics42Lifesciences32Biotechnology59Drug Discovery25Molecular Biology28Cancer34Clinical Trials24Cell Biology15Clinical Development18Life Sciences48

+12 more

Clinical ResearchImmunologyProtein ChemistryGenomicsStart-upsDrug DevelopmentBiochemistryTechnology TransferPharmaceutical IndustryCell CultureMedicineDue Diligence

From David's professional profile.

Deals · 5

AdvaxisBoard seat

via Israel Biotech Fund · filed Nov 2023 · $433.8K raise

Galmed PharmaceuticalsBoard seat

via Israel Biotech Fund · filed Aug 2017 · $350K raise

OrgenesisBoard seat

via Israel Biotech Fund · filed Dec 2015 · $10M raise

Tamir BiotechnologyBoard seat

via Israel Biotech Fund · filed Sep 2015 · $800K raise

Champions OncologyBoard seat

via Israel Biotech Fund · filed Mar 2015 · $14M raise

Attribution from SEC filings, press coverage, and firm rosters.

Colleagues at Israel Biotech Fund

Ido Zairi

Co-Founder and Managing Partner at Israel Biotech Fund

Sarit Steinberg

Partner at Israel Biotech Fund

Yuval Cabilly

Co-Founder and Managing Partner at Israel Biotech Fund

Frequently asked questions

Who is David Sidransky?: Co-Founder and Managing Partner at Israel Biotech Fund
Where does David Sidransky work?: David Sidransky is Co-Founder and Managing Partner at Israel Biotech Fund.
What boards does David Sidransky sit on?: David Sidransky holds tracked board seats at Advaxis, Advaxis, Champions Oncology, Galmed Pharmaceuticals, Orgenesis, Tamir Biotechnology.
Where did David Sidransky go to school?: David Sidransky studied at Baylor College of Medicine (md, internal medicine); Brandeis University (bs, chemistry).

Same school

Also attended Baylor College of Medicine40

Bret L. BostwickMD, FAAP, FACMG, Venture Advisor at Breyer Capital Nessan BerminghamInvestor at Khosla Ventures Lucy LiuPrincipal at Longwood Fund Lovisa BackemarPartner at EIR Ventures Jonathan MercadoPrincipal at First Bight Ventures Collin McCollAnalyst at First Bight Ventures

+ 34 more

Also attended Brandeis University139

Santiago ReganDirector of Business Development at Redpoint Ventures Nicholas AdamsManaging Partner at Differential Ventures John KeiltyVenture Partner at Third Rock Ventures Kevin GillisPartner and Chief Operating Officer at Third Rock Ventures Seth LieblichInvestment Team at 8VC Alex MorganInvestor at Khosla Ventures

+ 133 more

Shared employers

Also worked at Johns Hopkins University125

Nicole GaudelliEntrepreneur in Residence at GV (Google Ventures)Jun JeonInvestor at Khosla Ventures Lindsay MontiGeneral Counsel and CCO at JMI Equity Linda CuretonBoard Member at Maryland TEDCO Paula AndreuInvestor at Kfund Aagam ShahPrincipal at Sands Capital Ventures

+ 119 more

Also worked at Champions Oncology, Inc.5

David MillerChief Financial Officer at Champions Oncology Rob BraininChief Executive Officer at Champions Oncology Maria ManciniChief Operating Officer at Champions Oncology Marianna ZipetoEVP, Growth, Strategy & Enablement at Champions Oncology Tammer FaridGeneral Manager, Data Business at Champions Oncology

Also worked at Teva Pharmaceuticals50

Catherine Pearce, DHSc, MBAAdvisor at CincyTech Elad BaronInvestment Professional at Key1 Capital Elaine ShannonPresident, Global Supply & Quality at Takeda Ventures Riki MozesVice President, Chief People Officer at Jerusalem Venture Partners (JVP)Jill DeSimoneDigital Pharma Advisor at Excelerate Health Ventures Perry NisenExecutive Advisor, Private Equity at Sofinnova Ventures

+ 44 more

Also worked at ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company7

Carl GordonManaging Partner at OrbiMed Ian JudsonInvestor at Valence Ventures Sumeet ShahVenture Scout at Prototype Capital Chad MayCSO at Orum Therapeutics Venture Capital Sarah TullerChief Regulatory Officer at Opus Genetics Bryan GreeneExecutive Officer at Quadrant Biosciences

+ 1 more